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INTRODUCTION 
The ability of America's medical care system to identify and 
eliminate inefficiency and waste is essential if this nation is to 
continue to enjoy its present high standard of health care. Drug use 
review is a control mechanism which represents one approach to the 
problem of assuring the quality and economy of the drug use process.^ 
A Drug Utilization Review (DUR) Program is an authorized, structured, 
and on-going program that reviews, analyzes and interprets patterns of 
drug usage in health care delivery systems against predetermined 
standards. The program identifies areas of suboptimal drug therapy 
and prescribes measures aimed at correcting deficiencies in an effort 
to maintain the highest quality of patient care attainable. Thus, a 
Drug Utilization Review Program is a quality assurance program for 
drug therapy. The Joint Commission on Accreditation of Hospitals 
requires that hospitals conduct Drug Utilization Reviews to maintain 
accreditation. A DUR involves the development of criteria of appropri-
ate drug usage for a specific indication against which the current use 
of a drug is evaluated. The criteria are based on current literature 
and the clinical expertise of the medical staff and may address 
justification for use, process or outcome issues. 
Knapp et al^ have published guidelines for the development and 
application of criteria in drug use review programs. The authors 
present and discuss the definition of terms used by the Professional 
Standards Review Organization (PSRO) pertaining to DURs and present a 
2 
system of criteria classification. The PSRO Council defines criteria 
as predetermined elements against which aspects of the quality of a 
medical service may be compared. They are developed by professionals 
relying on professional expertise and on the professional literature. 
Antibiotic use has been identified as an area with frequent 
2 3 
overuse and misuse. ' Estimates indicate 30 to 40 percent of hos-
pitalized patients receive an antibiotic sometime during their hospital 
4 5 
stay ' and antibiotics account for 25 to 35 percent of this country's 
3 5 
expenditure for ethical pharmaceuticals. ' Maki and Schuna found 
antibiotics used for surgical prophylaxis less likely to be appropri-
ate (47 percent appropriate) than therapy given for presumed infection 
3 
(65 percent appropriate). Other investigators have found that 
misguided prophylaxis accounts for over one-half of the inappropriate 6 4 antibiotic therapy in their hospitals. Shapiro et al reported that 
74 percent of prophylactic drugs used in the general hospitals of 
Pennsylvania were administered for more than two days. 
Methods employed to decrease inappropriate use of antibiotics 
include formulary restriction, educational programs, and a novel 
prescription system. Durbin et al investigated the use of a system 
in which the physicians were required to categorize antibiotic use as 
prophylactic, empiric or therapeutic. Prophylactic antibiotics were 
automatically discontinued after two days. The investigators found 
statistically significant reductions in the percentage of patients 
receiving prophylactic antibiotics and in the mean duration of such 
prophylaxis after introduction of the system. 
Other investigators have compared educational programs designed 
to improve antibiotic prescribing and have shown that face-to-face 
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communication with practitioners is significantly more effective in 
bringing about behavior changes than providing printed material alone. 
8 
Avorn and Soumerai compared changes in prescribing patterns of 
randomly assigned physicians who were offered personal educational 
visits by clinical pharmacists along with a series of mailed "unadver-
tisements" to physicians receiving mailed print materials only. A 
statistically significant (p = 0.0006) reduction in the number of 
prescriptions for cephalexin and other target drugs was observed in 
9 
the group receiving face-to-face communication. Schaffner et al 
found similar changes in antibiotic prescribing when they compared a 
personal visit by a physician to a mailed brochure. Johnson et al^ 
instituted an educational program to improve gentamicin prescribing 
patterns of physicians directed primarily at the medical and surgical 
housestaff. In the preeducational review period, 57 of 109 courses of 
gentamicin (52 percent) were found acceptable. Following the educa-
tional program, 93 *of 120 courses (78 percent; p < 0.001) were 
acceptable. 
A screening audit conducted in the summer of 1983 of patients 
undergoing cesarean delivery at the University of Utah Hospital 
revealed the antibiotic prophylaxis being employed included various 
drugs and various durations, some extending greater than two days. 
This study presents the literature used to develop DUR criteria for 
appropriate prophylaxis of non-elective cesarean delivery, the results 
of the DUR and the effects on subsequent prophylactic courses after 
presenting the literature review used in criteria development and the 
findings of the DUR to the Obstetrics and Gynecology (OB-GYN) house-
staff and faculty. 
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OBJECTIVES 
1. Develop criteria for appropriate antibiotic prophylaxis for 
cesarean sections. 
2. Conduct a Drug Utilization Review of antibiotic prophylaxis for 
cesarean deliveries at the University of Utah Hospital during the 
first six months of 1983. 
3. Present findings of the DUR and a review of supporting literature 
to OB-GYN housestaff. 
4. Conduct a subsequent DUR to evaluate the effects of the presenta-
tion on antibiotic prophylaxis. 
5. Recommend additional measures if indicated to increase the 
incidence of appropriate antibiotic prophylaxis for cesarean 
section. 
DEVELOPMENT OF CRITERIA 
In developing criteria for a specific indication the following 
questions must be answered: Is any drug effective for the specific 
indication? Is any drug or combination of drugs more effective than 
others? What is the optimal length of drug administration? Is drug 
toxicity a significant factor? Which effective regimens are the least 
expensive? The primary literature was used to help answer these 
questions and develop the criteria; all studies cited are randomized, 
placebo-controlled and double-blind unless otherwise noted. 
Gibbs et al^ published the first randomized placebo controlled 
double-blind study investigating antibiotic prophylaxis exclusively in 
cesarean deliveries in 1972. The authors compared a combination of 
ampicillin one gram, methicillin one gram and kanamycin 500 mg ini-
tiated 15 to 30 minutes pre-operatively repeated 2 and 8 hours 
5 
post-operatively to placebo. The febrile morbidity was 29 percent for 
the treatment group versus 61 percent for the placebo group. These 
findings were statistically significant (p < 0.05). This study estab-
lished that patients undergoing cesarean deliveries can benefit from 
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prophylactic antibiotics. In 1973, Gibbs and coworkers published a 
similar study comparing only ampicillin one gram plus kanamycin 500 mg 
to placebo with similar results (24 percent versus 65 percent infec-
13 
tion rate, p < 0.05). Moro and Andrews compared cephalothin 
followed by cephalexin by mouth to complete five days of prophylaxis 
versus placebo. The febrile morbidity was 8 percent and 29 percent, 
respectively, but no analysis was presented. Thus the early 
literature investigated combination regimens for short durations and 
single drug regimens for long courses of prophylaxis all of which were 
more effective than placebo. 
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Gall studied the use of cefazolin one gram intramuscularly on 
call to the operating room followed by cephalothin two grams intra-
venously 6, 12, and 24 hours post-operatively and found the regimens 
to be significantly more efficacious than a similarly administered 
placebo (17.4 percent versus 40.8 percent infections, p < 0.05). 
Rehu and Jahkola^ compared narrow-spectrum (benzyl penicillin) versus 
broad-spectrum (clindamycin plus gentamicin) pre-operative antimicro-
bial prophylaxis. Both regimens proved effective in reducing post-
operative endometritis: from 33 percent in the placebo group to 6.5 
percent in the penicillin treated group and 9.5 percent in the clinda-
mycin plus gentamicin treated group (p < 0.05). McCowan and 
Jackson^ found metronidazole 500 mg given intravenously prior to the 
cesarean section followed by two grams rectally after surgery failed 
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to reduce the incidence of infection post-operatively. With the data 
from these studies one can surmize that relative narrow-spectrum 
prophylaxis is as effective as a broad-spectrum combination prophy-
laxis, while anaerobic antibiotic prophylaxis alone is no more effec-
tive than placebo. A single agent with aerobic and anaerobic activity 
appears to be effective. 
D'Angelo and Sokol''''' conducted the only comparison of the rela-
tive effectiveness of short and long courses of therapy versus no 
prophylaxis within a single patient population. No significant 
difference was found in the development of endometritis and/or wound 
infections between patients receiving cefazolin one gram every six 
hours for four doses and cefazolin one gram every six hours for eight 
doses followed by cephalexin 500 mg every six hours by mouth to 
complete five days of prophylaxis. The difference in the incidence of 
endometritis and/or wound infection between the control group (29.3%) 
and both the short- (9.4%) and long- (5.0%) course group were found to 
be statistically significant (p < 0.025). Although the newer, 
broader-spectrum antibiotics, third generation cephalosporins and 
extended spectrum penicillins have been shown to be effective, no 
direct evidence exists to indicate that they are clinically more 
efficacious than the less expensive penicillins or first generation 
cephalosporins, i.e., ampicillin or cefazolin. Toxicity is minimal 
with these regimens as no antibiotics had to be discontinued secondary 
to toxicity in the above cited studies. 
Based on this literature and the expertise of the OB-GYN faculty, 
the criteria for appropriate antibiotic prophylaxis of cesarean 
section were developed. The accepted criteria were one or two grams 
of ampicillin, cefoxitin or a first generation cephalosporin injected 
intravenously every 6 hours for a period not to exceed 24 hours. 
Patients allergic to both penicillins and cephalosporins should 
receive any regimen with a similar spectrum of activity that is not 
contraindicated for the patient. 
Cefoxitin is included as an appropriate antibiotic for prophy-
laxis from a theoretical standpoint based on its spectrum of activity. 
Cefoxitin has activity against the major pathogens found in patients 
undergoing cesarean section (namely anaerobes, particularly 
Bacteroides fragilis, gram-negative enteric organisms and group B 
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streptococci). Hawrylshyn et al demonstrated cefoxitin two grams as 
a single dose at the time of cord clamping was statistically signifi-
cantly better than placebo (9.4 percent versus 29.3 percent incidence 
of endometritis). 
METHODS 
The initial phase of the study was a Drug Utilization Review of 
prophylactic antibiotics used in patients undergoing cesarean delivery 
at the University of Utah Hospital from January 1 to June 30, 1983. 
The medical charts of 159 patients were reviewed, of these patients, 
87 (55 percent) received prophylactic antibiotics. Prophylactic 
antibiotics were defined as any antibiotics the patient received 
beginning with the perioperative period and continuing until ordered 
to be stopped by the physician or until the patient manifested clini-
cal signs of infection as documented by progress notes or temperature 
recordings. Patients receiving prophylaxis for prevention of subacute 
bacterial endocarditis were excluded. Patients not receiving prophy-
laxis were, for the most part, those who underwent elective 
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repeat cesarean sections or who were already receiving therapeutic 
antibiotics. Retrospective information obtained from the charts 
included patient number, time of delivery, history of drug allergies, 
antibiotic course, the original post-operative order verbatum and 
febrile course. Because a patient could receive five doses of antibio-
tics in a 24 hour period, excess cost of prophylaxis was estimated by 
calculating the cost, based on pharmacy charges, of the prophylactic 
antibiotics the patient received, minus the cost of five doses of the 
same drug if it was one of the appropriate antibiotics. When the 
antibiotic used was not one of the three designated antibiotics the 
cost of five doses of ampicillin 1 gram was subtracted from the 
charges incurred by the prophylactic antibiotics the patient actually 
received to calculate the maximal savings and cefoxitin 2 grams was 
substituted for ampicillin to calculate the minimal savings. Also 
listed are similar figures for net hospital acquisition cost for the 
antibiotics, administration sets and intravenous solutions. 
The results of the DUR and supporting data were presented during 
a meeting of the OB-GYN housestaff and faculty. Particular attention 
was given to potential cost savings and to limiting prescriptions to a 
specific number of doses to avoid extended prophylaxis. A brief 
written summary of the DUR was given to everyone attending the meeting 
(Appendix I). 
The next phase of the study was the completion of a second brief 
DUR covering the 50 consecutive cesarean deliveries immediately 
preceding and the same number immediately following the presentation 
of results to the housestaff. This phase covered a period over which 
there was minimal change in housestaff on the OB-GYN unit. The 
medical staff on the unit was unaware of the audit being conducted. 
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Retrospective data on antibiotic use were collected and changes 
in the prescribing patterns were analyzed. Chi square analysis was 
then completed comparing the incidence of inappropriate prophylaxis 
for the period before the meeting versus the period following the 
meeting. Statistical significance was considered p < 0.05. 
RESULTS AND DISCUSSION 
The information obtained from the first DUR was presented to the 
housestaff on April 12, 1984. Table 2 presents the data from the 
charts of the 50 consecutive patients having cesarean deliveries prior 
to the meeting versus the same data on 50 consecutive cesarean section 
patients following the meeting covering the period from February 7 to 
June 14, 1984. The incidence of inappropriate prophylaxis was not 
significantly different. However, results, both prior to (77 percent) 
and after (89 percent) the meeting differed from those in the initial 
DUR when only 41 percent of the prophylactic antibiotic courses met 
the criteria. 
Although presenting the data from the DUR to the housestaff did 
not result in statistically significant increase in appropriate 
antibiotic prophylaxis used in cesarean sections, a trend of improve-
ment was noted. Possibly the observation period of the follow-up DUR 
was too brief to show changes following the presentation or the 
effects on prescribing behavior of the housestaff were short-lived. 
Other factors may have influenced prescribing patterns between 
the time of the initial DUR and the follow-up study. Such factors 
might include the growing emphasis on reducing medical costs, the 
influence of the more recent literature demonstrating short courses of 
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prophylaxis to be as effective as extended prophylaxis, and finally, 
changes in the housestaff personnel over the year may have affected 
the results. The housestaff change continuously during the year and a 
single physician could greatly increase the incidence of extended 
prophylaxis during a short observation period. 
CONCLUSION 
The incidence of inappropriate prophylaxis has decreased substan-
tially from the previous year but the rate ideally should be zero. 
Efforts to eliminate inappropriate antibiotic use must be maintained. 
Continued monitoring is indicated particularly following changes in 
housestaff as the incidence appears to fluctuate from time to time. 
Possibly the pharmacists providing services to the obstetrics unit 
could monitor the prophylactic antibiotic use and intervene when 
inappropriate orders are written. 
Further measures to consider include additional educational 
programs such as in-services, follow-up discussion at later housestaff 
meetings or possibly a grand rounds on the topic. Another alternative 
to consider is an automatic stop order for prophylactic antibiotics 
similar to the system used by Durbin that reduced the incidence of 
inappropriate prophylaxis.^ 
. 
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Table 1. Initial DUR Results 
Number of cesarean sections performed 
January-June 1983 171 
Number of charts reviewed 156 
Number of patients receiving post-operative 
antibiotics 106 
Number of patients with signs of infection 
(excluded) 19 
Number of prophylactic antibiotic courses 
evaluated 87 
Number of prophylactic antibiotic courses 
meeting criteria 36 (41%) 
Number of prophylactic antibiotic courses not 
meeting criteria 51 (59%) 
Estimated excess patient charges incurred . . $ 4,703.34 - 4,867.36 
Estimated excess patient charges incurred 
per year3 $11,185.51 - 11,575.58 
Estimated excess hospital acquisition cost 
per year3' $ 2,213.89 - 2,641.66 
SL 
Minimal and maximal savings based on the use of the most expensive 
appropriate drug (cefoxitin 2 grams) and the least expensive drug 
(ampicillin 1 gram), respectively, in place of inappropriate drugs 
prescribed. 
k Based on net acquisition cost for the antibiotics, intravenous 
solutions and administration sets. 
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Table 2. Follow-up DUR Results 
Pre-Presentation Post-Presentation 
Number of cesarean sections 
performed 
Number of patients excluded 
(no prophylaxis, infected or 
defective heart valve) 
Number of patients receiving 
prophylaxis 
Number of appropriate prophylactic 
courses 

















A UTILIZATION REVIEW OF ANTIBIOTIC PROPHYLAXIS 
OF CESAREAN SECTION 
The Joint Commission on Accreditation of Hospitals requires that 
a hospital conduct Drug Utilization Reviews (DUR). A DUR involves 
developing criteria of appropriate drug usage for a specific indica-
tion against which the current use of drugs is evaluated. The cri-
teria are based on current literature and the clinical expertise of 
the medical staff. 
This article presents a review of the literature from which the 
criteria were developed for the prophylactic use of antibiotics in 
patients undergoing cesarean section. Also, included are the results 
of applying these criteria to 156 cesarean deliveries at the 
University of Utah Hospital. 
Contained in Table 1 are the results of several prospective 
randomized controlled studies investigating the use of prophylactic 
antibiotics in patients undergoing cesarean deliveries. Gibbs pub-
lished the first randomized placebo controlled double blinded studies 
investigating prophylaxis in cesarean section exclusively. The work 
that has followed shows many regimens to be safe and effective pro-
vided the regimen contains aerobic and anaerobic activity and is given 
perioperatively. The more recent literature supports short courses, 
i.e., less than 24 hours, to be as clinically effective as prophylaxis 
extended over several days. Although the new broad spectrum antibio-
tics, second and third generation cephalosporins and the extended 
spectrum penicillins, have been shown to be effective, no direct 
evidence exists to indicate that they are more effective 
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clinically than the less expensive penicillins or first generation 
cephalosporins, i.e., ampicillin or cefazolin. 
Based on the current literature the criteria for this DUR are 
ampicillin or a first generation cephalosporin or cefoxitin admin-
istered intravenously every six hours for no longer than 24 hours. No 
studies have been published regarding prophylaxis in patients allergic 
to both penicillins and cephalosporins, therefore an appropriate 
choice for these patients would be any regimen with a similar spectrum 
of activity that is not contraindicated for the patient. 
The medical charts of 156 patients undergoing cesarean section 
during the first six months of 1983 were available for review. One 
hundred six patients received perioperative antibiotics. Nineteen of 
these patients were either febrile or considered to be infected at 
delivery or during the first 24 hours post-cesarean section and were 
excluded from evaluation. Therefore, 87 post-cesarean delivery 
antibiotics courses were evaluated using the above developed criteria. 
Fifty-one of the prophylactic courses did not meet the criteria. The 
estimated excess patient charge incurred is $4,867.36. This cost is 
derived from the difference in the cost of the prophylaxis the patient 
actually received versus the cost that would have occurred using the 
criteria. 
The major reason for the increased cost was not from the use of 
more expensive antibiotics but from extended periods of prophylaxis 
beyond 24 hours. It was apparent from reviewing the written orders 
that when the number of doses or length of therapy was specified in 
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Ampicillin lg + Methicillin lg + Kanamycin 0.5g 
I.M. 15-30 min. pre-op + 2 & 8 hrs post delivery 
Placebo control, double blind 
Ampicillin lg + Kanamycin l/2g 
I.M. 15-30 min. pre-op + 2 & 8 hrs post delivery 
Placebo control, double blind 
Cephalothin 2g I.V. 15-30 min. pre-op followed 
by lg I.V. q6 hrs for 36 hrs followed by Cephalexin 
500 mg q6 hrs P.O. until 5th post-op day 
Placebo control, double blind 
Pen G 10 million units I.V. continuous infusion 
began 30 min. pre-op stopped 4 hrs post-op 
versus 
Clindamycin 500 mg I.V. continuous infusion began 
30 min pre-op stopped 4 hrs. post-op plus 
Gentamicin 80 mg I.M. 30 min pre-op double blind 
Metronidazole 500 mg I.V. pre-op plus 2g rectal 
suppository given at the completion of surgery 
Placebo control, double blind 
Cefazolin lg I.V. q6 hrs for 24 hrs 
versus 
Cefazolin lg q6 hrs for 8 doses followed by 





27% (9/33) 61% (17/28) 
p .05 
24% (8/34) 65% (22/34) 
p .05 
8% (6/74) 29% (20/74) 
no analysis presented 
Endometritis 
Treatment Control 





37% (13/35) 34% (13/38) 
Not Significant 
Endometritis and/or Wound Infection 
Treatment Control 
29% (7/24) 65% (20/31) 





U. of Toronto 
Cefoxitin 2g at the time of cord clamping 
versus 
Cefoxitin 2g at the time of cord clamping 
and 4 and 8 hours post operatively 





5.0% (3/60) 29.3% (17/58) 
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